Bleeding
Also known as: Bleed / Hemorrhage term / Hem / Hemorrhage, unspecified / Haemorrhage, unspecified / Extravasation blood / Blood loss of (NOS) / Hemorrhage NOS / Haemorrhage / Haemorrhage NOS / Hemorrhage (NOS) / Hemorrhage
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB11239 | Aluminum sulfate | A medication used to prevent infections and to treat minor bleeding. |
| DB09329 | Antihemophilic factor (recombinant), PEGylated | For the management of hemophilia A (congenital factor VIII deficiency) [FDA label], . This medication is a human antihemophilic factor indicated in adolescent and adult patients (12 years and older)... |
| DB00025 | Antihemophilic factor, human recombinant | A form of recombinant coagulation Factor VIII used to treat hemophilia A, von Willebrand disease, and Factor XIII deficiency. |
| DB14473 | Beroctocog alfa | Beroctocog alfa is indicated for the prevention and control of bleeding in patients with hemophilia A or acquired Factor VIII (FVIII) deficiency. It is also indicated for surgical/invasive procedures in... |
| DB09310 | Catridecacog | A recombinant FXIII subunit‐A molecule evaluated for clotting factor replacement therapy in congenital FXIII deficiency. |
| DB00100 | Coagulation Factor IX (Recombinant) | A form of recombinant human coagulation Factor IX used to treat hemophilia B. |
| DB00036 | Coagulation factor VIIa Recombinant Human | A form of recombinant human coagulation Factor VII used to treat hemophilia A and B. |
| DB13148 | Coagulation factor X human | A coagulation factor used to treat Factor X deficiency to control bleeding. |
| DB00035 | Desmopressin | A synthetic analog of vasopressin used to reduce renal excretion of water in central diabetes insipidus and nocturia. |
| DB16662 | Efanesoctocog alfa | A recombinant DNA-derived, Factor VIII concentrate indicated for routine prophylaxis, on-demand treatment and control of bleeding episodes, and perioperative management of bleeding in patients with hemophilia A. |
| DB11607 | Efmoroctocog alfa | A recombinant Factor VIII used to treat and prevent bleeding in hemophilia A. |
| DB11330 | Factor IX Complex (Human) | A Factor IX complex used to prevent and treat bleeding episodes in hemophilia B or vitamin K antagonist therapy. |
| DB09222 | Fibrinogen human | A hemostatic agent used for the treatment of acute bleeding episodes in patients with congenital fibrinogen deficiency, including afibrinogenemia and hypofibrinogenemia. |
| DB11571 | Human thrombin | A platelet activating factor used to treat minor bleeding. |
| DB13998 | Lonoctocog alfa | A recombinant Factor VIII used to treat hemophilia A to control bleeding. |
| DB15944 | Menadione bisulfite | Not Annotated |
| DB11311 | Prothrombin | A coagulation factor used for emergency reversal of vitamin K antagonist therapy. |
| DB11606 | Susoctocog alfa | A recombinant Factor VIII used to treat and prevent bleeding in hemophilia A. |
| DB00302 | Tranexamic acid | An antifibrinolytic used to reduce or prevent hemorrhagic episodes, especially in the context of hyperfibrinolytic disorders. |
| DB09109 | Turoctocog alfa | An antihemorrhagic agent used for the treatment and prophylaxis of bleeding in patients of all ages with haemophilia A (congenital factor VIII deficiency). |
| DB13133 | Von Willebrand factor human | A blood clotting factor used to manage bleeding episodes in von Willebrand disease and hemophilia A. |
| DB12872 | Vonicog alfa | Vonicog alfa is indicated for the on-demand treatment and control of bleeding episodes in adults previously diagnosed with von Willebrand disease. Vonicog alfa contains only the vWF and thus, its... |